Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECT

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Rieckmann P, Ziemssen T, Penner IK, Raji A, Wagner T, Richter J, Zettl UK.

Verlag

Publisher-Information
Adv Ther. 2022 Jun;39(6):2749-2760.

Link

Zur Publikation (externer Server)
https://doi.org/10.1007/s12325-022-02100-w

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2022